 |
|
|
| |
Ibalizumab demonstrates real-world durability in people living with multi-drug resistant HIV
|
| |
| |
CROI 2026 Feb 22-25 Denver
Princy N. Kumar1, Smitha Gudipati2, Charlotte-Paige Rolle3, Christina Harbison4, Namrata Shah5, Samir Kumar Gupta6, Jihad Slim7, Archana Asundi8, and Kaitlin Anstett9, on behalf of the PROMISE-US Investigators
1Georgetown University School of Medicine, Washington, DC, USA, 2Henry Ford Hospital, Detroit, MI, USA, 3Orlando Immunology Center, Orlando, FL, USA, 4Prism Health North Texas, Dallas, TX, USA, 5Whitman Walker Institute,
Washington DC, USA, 6Indiana University School of Medicine, Indianapolis, IN, USA, 7New York Medical College, Valhalla, NY, USA, 8Boston Medical Center, Boston, MA, USA, 9Theratechnologies, Inc, Montreal, Canada
|
| |
|
|
|
|
|
